SIGMA RECEPTOR-BINDING AGENT
PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpip...
Gespeichert in:
Hauptverfasser: | , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | YAMANISHI YOSHIHARU SENAGA MASAHIRO SUGIMOTO HACHIRO IIMURA YOICHI |
description | PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_JPH11349481A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>JPH11349481A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_JPH11349481A3</originalsourceid><addsrcrecordid>eNrjZJAJ9nT3dVQIcnV2DQjxD9J18vRz8fRzV3B0d_UL4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8V4BHoaGxiaWJhaGjsbEqAEAbpsg7w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>SIGMA RECEPTOR-BINDING AGENT</title><source>esp@cenet</source><creator>YAMANISHI YOSHIHARU ; SENAGA MASAHIRO ; SUGIMOTO HACHIRO ; IIMURA YOICHI</creator><creatorcontrib>YAMANISHI YOSHIHARU ; SENAGA MASAHIRO ; SUGIMOTO HACHIRO ; IIMURA YOICHI</creatorcontrib><description>PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>1999</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991221&DB=EPODOC&CC=JP&NR=H11349481A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=19991221&DB=EPODOC&CC=JP&NR=H11349481A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>YAMANISHI YOSHIHARU</creatorcontrib><creatorcontrib>SENAGA MASAHIRO</creatorcontrib><creatorcontrib>SUGIMOTO HACHIRO</creatorcontrib><creatorcontrib>IIMURA YOICHI</creatorcontrib><title>SIGMA RECEPTOR-BINDING AGENT</title><description>PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1999</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJAJ9nT3dVQIcnV2DQjxD9J18vRz8fRzV3B0d_UL4WFgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8V4BHoaGxiaWJhaGjsbEqAEAbpsg7w</recordid><startdate>19991221</startdate><enddate>19991221</enddate><creator>YAMANISHI YOSHIHARU</creator><creator>SENAGA MASAHIRO</creator><creator>SUGIMOTO HACHIRO</creator><creator>IIMURA YOICHI</creator><scope>EVB</scope></search><sort><creationdate>19991221</creationdate><title>SIGMA RECEPTOR-BINDING AGENT</title><author>YAMANISHI YOSHIHARU ; SENAGA MASAHIRO ; SUGIMOTO HACHIRO ; IIMURA YOICHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_JPH11349481A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1999</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>YAMANISHI YOSHIHARU</creatorcontrib><creatorcontrib>SENAGA MASAHIRO</creatorcontrib><creatorcontrib>SUGIMOTO HACHIRO</creatorcontrib><creatorcontrib>IIMURA YOICHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>YAMANISHI YOSHIHARU</au><au>SENAGA MASAHIRO</au><au>SUGIMOTO HACHIRO</au><au>IIMURA YOICHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>SIGMA RECEPTOR-BINDING AGENT</title><date>1999-12-21</date><risdate>1999</risdate><abstract>PROBLEM TO BE SOLVED: To prepare a sigma receptor-binding pharmaceutincal agent highly effective in antagonism or pungency to a sigma receptor, having safety and useful as a preventive, therapeutical and ameliorative agent, etc., for schizophrenia and aporioneurosis by including a specific benzylpiperidine derivative as an active component. SOLUTION: This pharmaceutical agent is prepared by including a benzylpiperidine of formula I [the bond of formula II is a single or double bond; R is an atomic group of formula III or the like; R is H or a lower alkoxy; (n) is 0-4] or its pharmacologically acceptable salt [e.g. 1-benzyl-4-(3,4- dihydro-4-oxoquinazolin-3-yl)piperidine, or the like] as an active component. The dose of the compound of formula I is pref. 1-500 mg/day and the pharmaceutical agent is oral administration, by intravenous injection, by intramuscular injection, by per rectum administration or by percutaneous administration.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_JPH11349481A |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | SIGMA RECEPTOR-BINDING AGENT |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T05%3A35%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=YAMANISHI%20YOSHIHARU&rft.date=1999-12-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EJPH11349481A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |